|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|
| 化学式 | C25H23Cl2N7O4 |
|||
| 分子量 | 556.4 | CAS No. | 1134156-31-2 | |
| Solubility (25°C)* | 体外 | DMSO | 100 mg/mL (179.72 mM) | |
| Water | Insoluble | |||
| Ethanol | Insoluble | |||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
||||
| 製品説明 | VER155008は、HSP70、HSC70、およびGRP78(HSPA5、Bip)のセルフリーアッセイにおいて、それぞれ0.5 μM、2.6 μM、および2.6 μMのIC50を示す強力なHsp70ファミリー阻害剤であり、HSP90に対して100倍以上の選択性を示します。VER155008はautophagyを阻害し、HSP90クライアントタンパク質のレベルを低下させます。 |
|---|---|
| in vitro | VER-155008 inhibits the proliferation of human breast and colon cancer cell lines BT474, MB-468, HCT116, and HT29 with GI50s in the range 5.3-14.4 μM, and induces Hsp90 client protein degradation in both HCT116 and BT474 cells. In the 8505C and FRO cells, this compound reduces the cell viability and elevates the percentage of dead cells in a time- and dose- dependent manner. It causes a dose-dependent inhibition of cytokine-dependent AML cell proliferation. This chemical shows an effective inhibition of cell proliferation in A549 and H1975 cells. |
| in vivo | In HCT116 tumor bearing mice, VER-155008 (25 or 40 mg/kg, i.v.) demonstrates rapid metabolism and clearance, along with tumor levels below the predicted pharmacologically active level. |
| キナーゼアッセイ | Hsc70, Hsp70 and Grp78 fluorescence polarisation (FP) assay | |
|---|---|---|
| The FP assay for Hsp70 is conducted in aqueous buffer consisting of 100 mM Tris pH 7.4, 150 mM KCl and 5 mM CaCl2, in a final assay volume of 100 µl, using 96 well black polystyrene high bind plates with a Fusion plate reader. N6-(6-amino)hexyl-ATP-5-FAM and the in-house protein preparation of GST-HSP70 3-382 have final concentrations in the assay of 20 nM and 400 nM, respectively. Compounds are tested as 10-point IC50s, with a final DMSO concentration of 5%. Assay mixtures are incubated for 3 h prior to reading on the Fusion (ex 485 nm; em 535 nm). The data is fitted using a 4 parameter logistical data model by XLFit 4. The FP assay for Hsc70 and Grp78 is carried out as described for Hsp70 using the same N6 -(6-amino)hexyl-ATP-5-FAM as the FP probe with the following modifications. For Hsc70, the protein and probe concentrations are 0.3 μM and 20 nM, respectively with a 30 min incubation at 22℃ while for Grp78, the protein and probe concentrations are 2 μM and 10 nM, respectively with a 2 h incubation at 22℃. The KD for the FAM-ATP probe was 0.24 μM for Hsc70 and 2 μM for Grp78. | ||
| 細胞アッセイ | 細胞株 | BT474, MB-468, HCT116, and HT29 cells |
| 濃度 | 50 μM | |
| 反応時間 | 72 h | |
| 実験の流れ | All cell lines are grown in DMEM/10% FCS with GlutaMAX-I in a humidified atmosphere of 5% CO2 in air. Cell proliferation is determined using the sulforhodamine B (SRB) assay. | |
| 動物実験 | 動物モデル | HCT116 tumor bearing |
| 投薬量 | 40 mg/kg | |
| 投与方法 | i.v. | |
|

, , Neuroscience, 2014, 281C:164-177.

Data from [Data independently produced by , , Antiviral Res, 2018, 150:39-46]

Data from [Data independently produced by , , Cell Signal, 2017, 30:130-141]
| A chaperone-proteasome-based fragmentation machinery is essential for aggrephagy [ Nat Cell Biol, 2025, 27(9):1448-1464] | PubMed: 40866512 |
| Pharmacological Modulation of the Unfolded Protein Response as a Therapeutic Approach in Cutaneous T-Cell Lymphoma [ Biomolecules, 2025, 15(1)76] | PubMed: 39858470 |
| Shiga Toxin Type 2 Aggravates G1/S Phase Cell Cycle Arrest, Mediating Caspase-Independent Cell Death under Hyperosmotic Conditions in the Kidney [ J Microbiol Biotechnol, 2025, 35:e2508015] | PubMed: 40915655 |
| USP8 and Hsp70 regulate endoreplication by synergistically promoting Fzr deubiquitination and stabilization [ Sci Adv, 2025, 11(12):eadq9111] | PubMed: 40106570 |
| Caspase-2 is a condensate-mediated deubiquitinase in protein quality control [ Nat Cell Biol, 2024, 26(11):1943-1957] | PubMed: 39482354 |
| Impairment of lipid homeostasis causes lysosomal accumulation of endogenous protein aggregates through ESCRT disruption [ Elife, 2024, 12RP86194] | PubMed: 39713930 |
| Small molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance [ Breast Cancer Res, 2024, 26(1):33] | PubMed: 38409088 |
| Synergistic anticancer activity of HSP70 and HSF1 inhibitors in colorectal cancer cells: A new strategy for combination therapy [ Biochim Biophys Acta Mol Basis Dis, 2024, 1871(3):167630] | PubMed: 39675530 |
| Hsp70 Negatively Regulates Autophagy via Governing AMPK Activation, and Dual Hsp70-Autophagy Inhibition Induces Synergetic Cell Death in NSCLC Cells [ Int J Mol Sci, 2024, 25(16)9090] | PubMed: 39201776 |
| HSP70 positively regulates translation by interacting with the IRES and stabilizes the viral structural proteins VP1 and VP3 to facilitate duck hepatitis A virus type 1 replication [ Vet Res, 2024, 55(1):63] | PubMed: 38760810 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。